aid: cellphire-therapeutics

name: CellPhire Therapeutics

description: 'CellPhire Therapeutics develops platelet‑based therapeutics to treat acute hemorrhage and promote vascular repair. Their platform includes CLPH‑511, a frozen activated platelet product, and the FPH platform targeting hemostasis and vascular permeability. The company aims to save lives in trauma, surgery, and critical care by providing innovative biologics that address platelet availability challenges.'

url: https://raw.githubusercontent.com/api-evangelist/cellphire-therapeutics/refs/heads/main/apis.yml

x-type: company

x-source: harvest:secondary-market

x-tier: profiled
x-tier-reason: enrichment pass 2026-10-07 (modular-v1; was harvest)

specificationVersion: '0.20'

created: '2026-10-07'

modified: '2026-10-07'

tags:
- Company
- Biotechnology
- Therapeutics
- Platelet
- Hemostasis

maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io

common:
- type: Hosts
  url: hosts/cellphire-therapeutics-hosts.yml
- type: Vendors
  url: vendors/cellphire-therapeutics-vendors.yml
- type: TermsOfService
  url: https://www.cellphire.com/terms-of-use
- type: Newsroom
  url: https://www.cellphire.com/news
- type: DomainSecurity
  url: security/cellphire-therapeutics-domain-security.yml
- type: Website
  url: https://www.cellphire.com

apis: []

x-coverage:
  state: unreadable
  reason: no-machine-readable-spec
  detail: No OpenAPI, AsyncAPI, GraphQL, or other contract discovered on api.cellphire.com or any docs host.
  evidence:
    - url: https://api.cellphire.com/openapi.json
      status: 0
  checked: '2026-10-07'
x-enrichment:
  date: '2026-10-07'
  status: enriched
  artifacts_added: 5
  pass: modular-v1
  engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local